Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,481 INR | -0.42% | +6.53% | -3.74% |
May. 14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
May. 13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.74% | 2.48B | |
-16.80% | 8.79B | |
+63.16% | 4.19B | |
-43.01% | 2.29B | |
-4.82% | 1.97B | |
-18.74% | 1.56B | |
-40.24% | 1.22B | |
+9.42% | 1.13B | |
+19.76% | 933M | |
-13.58% | 910M |
- Stock Market
- Equities
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Nomura Upgrades Dr. Lal PathLabs to Neutral From Reduce, Adjusts Price Target to INR1,864 From INR1,819